Association between P2X7 Receptor Polymorphisms and Bone Status in Mice
Journal of Osteoporosis · 2012
DOI: 10.1155/2012/637986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Osteoporosis, 2012. Verfasst von Susanne Syberg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre of Ageing and Osteoporosis, Departments of Diagnostics and Medicine, Glostrup University Hospital, 2600 Glostrup, Denmark. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: European Commission, Research Foundation on Hvidovre Hospital.
Abstract (Originalsprache)
Macrophages from mouse strains with the naturally occurring mutation P451L in the purinergic receptor P2X7 have impaired responses to agonists (1). Because P2X7 receptors are expressed in bone cells and are implicated in bone physiology, we asked whether strains with the P451L mutation have a different bone phenotype. By sequencing the most common strains of inbred mice, we found that only a few strains (BALB, NOD, NZW, and 129) were harboring the wild allelic version of the mutation (P451) in the gene for the purinergic receptor P2X7. The strains were compared by means of dual energy X-ray absorptiometry (DXA), bone markers, and three-point bending. Cultured osteoclasts were used in the ATP-induced pore formation assay. We found that strains with the P451 allele (BALB/cJ and 129X1/SvJ) had stronger femurs and higher levels of the bone resorption marker C-telopeptide collagen (CTX) compared to C57Bl/6 (B6) and DBA/2J mice. In strains with the 451L allele, pore-formation activity in osteoclasts in vitro was lower after application of ATP. In conclusion, two strains with the 451L allele of the naturally occurring mutation P451L, have weaker bones and lower levels of CTX, suggesting lower resorption levels in these animals, which could be related to the decreased ATP-induced pore formation observed in vitro . The importance of these findings for the interpretation of the earlier reported effects of P2X7 in mice is discussed, along with strategies in developing a murine model for testing the therapeutic effects of P2X7 agonists and antagonists upon postmenopausal osteoporosis.
Autor:innen und Institutionen
- Research Centre of Ageing and Osteoporosis, Departments of Diagnostics and Medicine, Glostrup University Hospital, 2600 Glostrup, Denmark.
Förderung
- European Commission
- Research Foundation on Hvidovre Hospital
Zitieren
APA
Syberg, S., Schwarz, P., Petersen, S., Steinberg, T. H., Jensen, J. E., Teilmann, J., & Jørgensen, N. R. (2012). Association between P2X7 Receptor Polymorphisms and Bone Status in Mice. Journal of Osteoporosis. https://doi.org/10.1155/2012/637986
Vancouver
Syberg S, Schwarz P, Petersen S, Steinberg TH, Jensen JE, Teilmann J, et al. Association between P2X7 Receptor Polymorphisms and Bone Status in Mice. Journal of Osteoporosis. 2012. doi:10.1155/2012/637986
BibTeX
@article{Syberg2012,
author = {Syberg, Susanne and Schwarz, Peter and Petersen, Solveig and Steinberg, Thomas H and Jensen, Jens-Erik Beck and Teilmann, Jenni and Jørgensen, Niklas Rye},
title = {Association between P2X7 Receptor Polymorphisms and Bone Status in Mice},
journal = {Journal of Osteoporosis},
year = {2012},
doi = {10.1155/2012/637986}
}
EUVIMED